Strategies for Enhanced CAR-T Cell Development, Part I

Chimeric Antigen Receptor (CAR)-T cell therapy is a promising development in cancer immunotherapy, but method optimization is necessary to produce the cells at scale. In this two-part webinar, Nucleus Biologics introduces a new resource for improving the CAR-T expansion process.

Get exclusive updates direct to your inbox.

Subscribe